Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the role of C16:0 ceramide in melanoma metastatic behavior and glycolysis, five common long-chain ceramides (C16:0,
C18
:0, C20:0, C22:0, C24:0) were tested in melanocyte and melanoma cell lines by LC-MS. We then treated non-metastatic and metastatic melanoma cells with PDMP and exogenous C16:0 to explore their effects on proliferation, migration, and glycolysis. The long-chain ceramide was also analyzed by LC-MS after treatment. C16:0 ceramide showed the highest levels in melanocyte and melanoma cells, with all melanomas higher than melanocytes. PDMP inhibited malignant behavior and glycolysis in melanoma, and caused the accumulation of intracellular C16:0. Exogenous C16:0 promoted melanoma glycolysis, but not malignant behavior, and decreased intracellular C16:0. Finally, pyruvate kinase (PK),
hexokinase
(HK), and lactic acid dehydrogenase (LDH) activity, key enzymes in glycolysis, were altered after treatment with PDMP and exogenous C16:0.
...
PMID:C16:0 ceramide effect on melanoma malignant behavior and glycolysis depends on its intracellular or exogenous location. 3226 39
The oleaginous yeast
Yarrowia lipolytica
has attracted much attention due to its ability to utilize a wide range of substrates to accumulate high lipid content and its flexibility for genetic manipulation. In this study, intracellular lipid metabolism in
Y. lipolytica
was tailored to produce fatty acid, a renewable oleochemical and precursor for production of advanced biofuels. Two main strategies, including blocking activation and peroxisomal uptake of fatty acids and elimination of biosynthesis of lipids, were employed to reduce fatty acid consumption by the native pathways in
Y. lipolytica
. Both genetic modifications improved fatty acid production. However, disruption of the genes responsible for assembly of nonpolar lipid molecules including triacylglycerols (TAGs) and steryl esters resulted in the deleterious effects on the cell growth. The gene
tesA
encoding thioesterase from
Escherichia coli
was expressed in the strain with disrupted
faa
genes encoding fatty acyl-CoA synthetases and
pxa1
encoding peroxisomal acyl-CoA transporter, and the titer of fatty acids resulted in 2.3 g/L in shake flask culture, representing 11-fold improvement compared with the parent strain. Expressing the native genes encoding acetyl-CoA carboxylase (ACC) and
hexokinase
also increased fatty acid production, although the improvement was not as significant as that with
tesA
expression. Saturated fatty acids including palmitic acid (C16:0) and stearic acid (
C18
:0) increased remarkably in the fatty acid composition of the recombinant bearing
tesA
compared with the parent strain. The recombinant expressing
tesA
gene resulted in high lipid content, indicating the great fatty acid producing potential of
Y. lipolytica
. The results highlight the achievement of fatty acid overproduction without adverse effect on growth of the strain. Results of this study provided insight into the relationship between fatty acid and lipid metabolism in
Y. lipolytica
, confirming the avenue to reprogram lipid metabolism of this host for overproduction of renewable fatty acids.
...
PMID:Metabolic Engineering of Oleaginous Yeast
Yarrowia lipolytica
for Overproduction of Fatty Acids. 3284 64